ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 53 filers reported holding ROIVANT SCIENCES LTD in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $86,587,580 | +1.3% | 8,191,824 | +1.1% | 0.00% | 0.0% |
| Q1 2024 | $85,440,741 | +7.5% | 8,106,332 | +14.6% | 0.00% | 0.0% |
| Q4 2023 | $79,459,561 | +21.4% | 7,075,651 | +26.3% | 0.00% | 0.0% |
| Q3 2023 | $65,437,972 | +200.2% | 5,602,566 | +159.1% | 0.00% | +100.0% |
| Q2 2023 | $21,794,895 | +67.0% | 2,162,192 | +22.2% | 0.00% | – |
| Q1 2023 | $13,054,054 | -0.9% | 1,768,842 | +7.3% | 0.00% | – |
| Q4 2022 | $13,174,703 | +160.0% | 1,648,899 | +4.8% | 0.00% | – |
| Q3 2022 | $5,067,000 | -17.9% | 1,573,575 | +3.8% | 0.00% | – |
| Q2 2022 | $6,172,000 | -5.3% | 1,516,349 | +14.9% | 0.00% | – |
| Q1 2022 | $6,519,000 | -44.2% | 1,319,499 | +13.8% | 0.00% | – |
| Q4 2021 | $11,690,000 | – | 1,159,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 66,719,779 | $705,228,064 | 66.32% |
| Patient Square Capital LP | 12,228,465 | $129,254,875 | 59.99% |
| Atalaya Capital Management LP | 1,714,843 | $18,125,891 | 40.31% |
| Two Seas Capital LP | 10,318,764 | $109,069,335 | 17.73% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $51,081,026 | 15.77% |
| Whitefort Capital Management, LP | 2,391,000 | $25,272,870 | 15.58% |
| STEMPOINT CAPITAL LP | 2,712,741 | $28,673,672 | 8.43% |
| Tejara Capital Ltd | 2,183,943 | $23,084,278 | 8.39% |
| Tyro Capital Management LLC | 1,744,327 | $18,437,536 | 8.36% |
| ADAR1 Capital Management, LLC | 4,150,009 | $43,865,595 | 8.28% |